Shenling Baizhu San ameliorates non-alcoholic fatty liver disease in mice by modulating gut microbiota and metabolites
Purpose: The prevalence of non-alcoholic fatty liver disease (NAFLD) and its related mortality is increasing at an unprecedented rate. Traditional Chinese medicine (TCM) has been shown to offer potential for early prevention and treatment of NAFLD. The new mechanism of "Shenling Baizhu San"...
Saved in:
Main Authors: | Dongliang Chen (Author), Yuanfei Wang (Author), Jianmei Yang (Author), Wanyi Ou (Author), Guiru Lin (Author), Ze Zeng (Author), Xiaomin Lu (Author), Zumin Chen (Author), Lili Zou (Author), Yaling Tian (Author), Aiping Wu (Author), Shelley E. Keating (Author), Qinhe Yang (Author), Chenli Lin (Author), Yinji Liang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Network pharmacology and gut microbiota insights: unraveling Shenling Baizhu powder's role in psoriasis treatment
by: Bin Tang, et al.
Published: (2024) -
Effect of Shenling Baizhu powder on immunity to diarrheal disease: A systematic review and meta-analysis
by: Qian Chen, et al.
Published: (2022) -
Effects of Shenling Baizhu powder on pyrotinib-induced diarrhea: analysis of gut microbiota, metabonomics, and network pharmacology
by: Jingjiang Lai, et al.
Published: (2022) -
Traditional Chinese medicine prescription Shenling BaiZhu powder to treat ulcerative colitis: Clinical evidence and potential mechanisms
by: Jing Chen, et al.
Published: (2022) -
Shenling Baizhu Powder Inhibits RV-SA11-Induced Inflammation and Rotavirus Enteritis via TLR4/MyD88/NF-κB Signaling Pathway
by: Xiaoyan Wang, et al.
Published: (2021)